Subchapter 1 - PHARMACEUTICAL SERVICES
- Section 10:51-1.1 - Introduction
- Section 10:51-1.2 - Participation of eligible providers
- Section 10:51-1.3 - Conditions for participation as a provider of pharmaceutical services
- Section 10:51-1.4 - Program restrictions affecting payment for prescribed drugs
- Section 10:51-1.5 - Basis of payment
- Section 10:51-1.6 - Discounts
- Section 10:51-1.7 - Prescription dispensing fee
- Section 10:51-1.8 - Compounded prescriptions
- Section 10:51-1.9 - Non-proprietary or generic dispensing
- Section 10:51-1.10 - Provider's usual and customary charge or advertised charge
- Section 10:51-1.11 - Covered pharmaceutical services
- Section 10:51-1.12 - Personal contribution to care requirements for NJ FamilyCare-Plan C and copayments for NJ FamilyCare-Plan D
- Section 10:51-1.13 - Non-covered pharmaceutical services
- Section 10:51-1.14 - Services requiring prior authorization
- Section 10:51-1.15 - Quantity of medication
- Section 10:51-1.16 - Dosage and directions
- Section 10:51-1.17 - Telephone-rendered original prescriptions
- Section 10:51-1.18 - Changes or additions to the original prescription
- Section 10:51-1.19 - Prescription refill
- Section 10:51-1.20 - Prescription Drug Price and Quality Stabilization Act
- Section 10:51-1.21 - Drug Efficacy Study Implementation (DESI)
- Section 10:51-1.22 - Drug manufacturers' rebate agreement
- Section 10:51-1.23 - Bundled drug service
- Section 10:51-1.24 - Claim submission
- Section 10:51-1.25 - Point-of-sale (POS) claims adjudication system
- Section 10:51-1.26 - Prospective drug utilization review (PDUR) program
- Section 10:51-1.27 - Medical exception process (MEP)